These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3913418)

  • 21. Research on the mechanisms of action of aneugenic chemicals and regulatory approaches for their control in the European Communities.
    Parry JM
    Environ Mol Mutagen; 1996; 28(3):248-53. PubMed ID: 8908183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Special committee report, Part II: Quantitative evaluation of chemicals that induce aneuploidy using the genetic activity profile method.
    Waters MD; Stack HF; Mavournin KH; Dellarco VL
    Basic Life Sci; 1985; 36():455-90. PubMed ID: 4096702
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of a streamlined bacterial mutagenicity assay, the MINISCREEN.
    Brooks TM
    Mutagenesis; 1995 Sep; 10(5):447-8. PubMed ID: 8544759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Legator MS; Bueding E; Batzinger R; Connor TH; Eisenstadt E; Farrow MG; Ficsor G; Hsie A; Seed J; Stafford RS
    Mutat Res; 1982 May; 98(3):319-74. PubMed ID: 7050697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of potential mammalian genotoxins using Drosophila: the need for a change in test strategy.
    Vogel EW
    Mutagenesis; 1987 May; 2(3):161-71. PubMed ID: 3325739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
    Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
    Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sister chromatid exchange studies in the chick embryo and neonate: actions of mutagens in a developing system.
    Bloom SE
    Basic Life Sci; 1984; 29 Pt B():509-33. PubMed ID: 6397191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutagenicity testing with eukaryotic microorganisms.
    Moustacchi E
    Arch Toxicol; 1980 Nov; 46(1-2):99-110. PubMed ID: 7016074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparisons of tests for aneuploidy.
    Parry JM; Parry EM
    Mutat Res; 1987 Dec; 181(2):267-87. PubMed ID: 3317028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutagenic activity of chemicals previously tested for carcinogenicity in the National Cancer Institute bioassay program.
    Dunkel VC; Simmon VF
    IARC Sci Publ; 1980; (27):283-301. PubMed ID: 7002779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Predictive value of short-term assays of chemical carcinogenesis].
    Laborda E; de la Peña E; Valcarce E; Canga C; Sladek F; Barrueco C
    Rev Esp Oncol; 1982; 29(3):547-55. PubMed ID: 6765349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proportions of mutagens among chemicals in commerce.
    Zeiger E; Margolin BH
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):219-25. PubMed ID: 11067778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-arabinose resistance test with Salmonella typhimurium as a primary tool for carcinogen screening.
    Dorado G; Pueyo C
    Cancer Res; 1988 Feb; 48(4):907-12. PubMed ID: 3276401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Problems concerned with microbial mutagenicity tests].
    Gericke D
    Onkologie; 1982 Feb; 5(1):30-2, 34-5. PubMed ID: 6461834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
    Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
    Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collaborative studies on the Salmonella/microsome mutagenicity assay.
    Dunkel VC
    J Assoc Off Anal Chem; 1979 Jul; 62(4):874-82. PubMed ID: 387710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of BALB/c-3T3 cells: V. Transformation responses of 168 chemicals compared with mutagenicity in Salmonella and carcinogenicity in rodent bioassays.
    Matthews EJ; Spalding JW; Tennant RW
    Environ Health Perspect; 1993 Jul; 101 Suppl 2(Suppl 2):347-482. PubMed ID: 8243403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.